Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Longo

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
ISME Communications|November 8, 2023
Aquatic reservoir of Vibrio cholerae in an African Great Lake assessed by large scale plankton sampling and ultrasensitive molecular methodsLuigi Vezzulli, Caterina Oliveri, Alessio Borello, et al.
Oncotarget|March 25, 2016
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionVito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro, et al.
Cancer Research|November 5, 2020
Radiomic Detection of EGFR Mutations in NSCLCGiovanni Rossi, Emanuele Barabino, Alessandro Fedeli, et al.
Cancer Research|September 3, 2009
Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patientsLorena Passoni, Luca Longo, Paola Collini, et al.
Clinical Breast Cancer|October 3, 2020
Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast CancerSimona Coco, Simona Boccardo, Marco Mora, et al.
Pediatric Blood & Cancer|May 1, 2015
Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma groupKatia Mazzocco, Raffaella Defferrari, Angela Rita Sementa, et al.
Molecular Cancer Therapeutics|April 27, 2018
A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma TherapyViktoryia Sidarovich, Marilena De Mariano, Sanja Aveic, et al.
Nature|August 30, 2008
Identification of ALK as a major familial neuroblastoma predisposition geneYaël P Mossé, Marci Laudenslager, Luca Longo, et al.
Cancers|July 27, 2022
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer PatientsSilvia Marconi, Michela Croce, Giovanna Chiorino, et al.
Clinical and Experimental Medicine|August 6, 2024
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumabCarlo Genova, Silvia Marconi, Giovanna Chiorino, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
ISME Communications|November 8, 2023
Aquatic reservoir of Vibrio cholerae in an African Great Lake assessed by large scale plankton sampling and ultrasensitive molecular methodsLuigi Vezzulli, Caterina Oliveri, Alessio Borello, et al.
Oncotarget|March 25, 2016
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionVito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro, et al.
Cancer Research|November 5, 2020
Radiomic Detection of EGFR Mutations in NSCLCGiovanni Rossi, Emanuele Barabino, Alessandro Fedeli, et al.
Cancer Research|September 3, 2009
Mutation-independent anaplastic lymphoma kinase overexpression in poor prognosis neuroblastoma patientsLorena Passoni, Luca Longo, Paola Collini, et al.
Clinical Breast Cancer|October 3, 2020
Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast CancerSimona Coco, Simona Boccardo, Marco Mora, et al.
Pediatric Blood & Cancer|May 1, 2015
Genetic abnormalities in adolescents and young adults with neuroblastoma: A report from the Italian Neuroblastoma groupKatia Mazzocco, Raffaella Defferrari, Angela Rita Sementa, et al.
Molecular Cancer Therapeutics|April 27, 2018
A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma TherapyViktoryia Sidarovich, Marilena De Mariano, Sanja Aveic, et al.
Nature|August 30, 2008
Identification of ALK as a major familial neuroblastoma predisposition geneYaël P Mossé, Marci Laudenslager, Luca Longo, et al.
Cancers|July 27, 2022
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer PatientsSilvia Marconi, Michela Croce, Giovanna Chiorino, et al.
Clinical and Experimental Medicine|August 6, 2024
Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumabCarlo Genova, Silvia Marconi, Giovanna Chiorino, et al.
Pageof 6